CURB-65 Score
Predicts 30-day mortality in community-acquired pneumonia (CAP) and guides the locus of care (outpatient vs inpatient vs ICU) and empirical antibiotic selection.
Total Score
/ 5
NICE / BTS Guidelines
-
Score 0-1: Low Severity
Mortality < 3%. Suitable for home treatment (oral Amoxicillin usually first-line). -
Score 2: Moderate Severity
Mortality ~9%. Consider short-stay hospital admission or hospital-at-home. Dual oral therapy (e.g., Amoxicillin + Macrolide). -
Score 3-5: High Severity
Mortality 15-40%. Urgent hospital admission required, consider ICU if score ≥ 4. IV antibiotics (e.g., Co-amoxiclav + Clarithromycin).
Note: CRB-65 (excluding Urea) can be used in primary care where immediate blood results are unavailable. A CRB-65 of 0 is low risk.
← Back to all tools